| |
Unit A
|
Unit B
|
|---|
|
N (%)
|
N (%)
|
|---|
|
Total events
|
938
|
1061
|
|
Hospitalizations
|
700 (75)
|
725 (68)
|
|
Treated with antimicrobials
|
648 (69)
|
747 (70)
|
|
Bacteremia episodes
|
146 (16)
|
121 (11)
|
|
Access exit site infection&
|
27 (3)
|
13 (1)
|
|
Access-related infections
|
85 (9)
|
41 (4)
|
|
Pathogens isolated#
|
65 (76)
|
31 (76)
|
|
Enterobacteriaceae
|
30 (46)
|
8 (26)
|
|
Pseudomonas aeruginosa
|
8 (12)
|
1 (3)
|
|
Staphylococcus aureus
|
11 (17)
|
15 (48)
|
|
Other gram positive cocci
|
13 (20)
|
6 (19)
|
|
Other $
|
3 (5)
|
1 (3)
|
- * Events – hospitalization, antibiotic treatment, positive blood culture, vascular exit site infection or
- catheter exchange due to infection
- & Access exit site infection – tunnelled catheter, 21/27 (78%) in unit A and 11/13 (85%) in unit B; AV graft and AV fistula, each, 3/27 (11%) in unit A and 1/13 (8%) in unit B
- # Pathogens could be isolated either from blood culture or exit site infection
- $ Other – unit A, 2 candida sp. and 1 polymicrobial; unit B, 1 anaerobe
